In 1994, Eberhart et al [15] described a differential overexpression of COX-2 mRNA in CRC and adenomatous polyps compared to normal tissues and proposed that COX-2 could be a control target for CRC [15]. Here, PTGS2 is linked to colorectal carcinoma.